Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in down syndrome

Clinical Proteomics

Volumn 10, Issue 1, 2013, Pages

  Cho, Chan Kyung J ^a   Drabovich, Andrei P ^b   Karagiannis, George S ^a,b   Martínez Morillo, Eduardo ^b   Dason, Shawn ^a   Dimitromanolakis, Apostolos ^b   Diamandis, Eleftherios P ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Amniocyte; Amniotic fluid cells; Down syndrome; Quantitative proteomics; Trisomy 21

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; NESTIN; PROTEOME;

AMNION CELL; ARTICLE; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; ISOTOPE LABELING; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TRISOMY 21;

EID: 84893137521     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-10-2     Document Type: Article

References (28)

1. Amano K, Sago H, Uchikawa C, Suzuki T, Kotliarova SE, Nukina N, Epstein CJ, Yamakawa K: Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for down syndrome. Hum Mol Genet 2004, 13:1333-1340. (Pubitemid 38967186)
2. Kahlem P, Sultan M, Herwig R, Steinfath M, Balzereit D, Eppens B, Saran NG, Pletcher MT, South ST, Stetten G, Lehrach H, Reeves RH, Yaspo ML: Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res 2004, 14:1258-1267. (Pubitemid 39029222)
3. Lyle R, Gehrig C, Neergaard-Henrichsen C, Deutsch S, Antonarakis SE: Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. Genome Res 2004, 14:1268-1274. (Pubitemid 39029223)
4. Mao R, Wang X, Spitznagel EL Jr, Frelin LP, Ting JC, Ding H, Kim JW, Ruczinski I, Downey TJ, Pevsner J: Primary and secondary transcriptional effects in the developing human down syndrome brain and heart. Genome Biol 2005, 6:R107.
5. Saran NG, Pletcher MT, Natale JE, Cheng Y, Reeves RH: Global disruption of the cerebellar transcriptome in a down syndrome mouse model. Hum Mol Genet 2003, 12:2013-2019. (Pubitemid 37038810)
6. Cho CK, Smith CR, Diamandis EP: Amniotic fluid proteome analysis from down syndrome pregnancies for biomarker discovery. J Proteome Res 2010, 9:3574-3582.
7. Buhimschi IA, Christner R, Buhimschi CS: Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 2005, 112:173-181. (Pubitemid 40188245)
8. Cho CK, Shan SJ, Winsor EJ, Diamandis EP: Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 2007, 6:1406-1415. (Pubitemid 47365438)
9. Underwood MA, Gilbert WM, Sherman MP: Amniotic fluid: Not just fetal urine anymore. J Perinatol 2005, 25:341-348. (Pubitemid 40645606)
10. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, Cho DJ, Kang SG, You J: Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007, 40:75-90. (Pubitemid 46103692)
11. Milunsky A: Amniotic fluid cell culture. In Genetic disorder and the fetus. Edited by Milunsky A. New York: Plenum Press; 1979:75-84.
12. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Bartsch A: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25:100-106. (Pubitemid 46087908)
13. Drabovich AP, Jarvi K, Diamandis EP: Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay. Mol Cell Proteomics 2012, 10: 004127.
14. Mann M: Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol 2006, 7:952-958. (Pubitemid 44871421)
15. Cho CK, Drabovich AP, Batruch I, Diamandis EP: Verification of a biomarker discovery approach for detection of down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay. J Proteomics 2011, 74:2052-2059.
16. Lee EJ, Seo SR, Um JW, Park J, Oh Y, Chung KC: NF-kappaB-inducing kinase phosphorylates and blocks the degradation of down syndrome candidate region 1. J Biol Chem 2008, 283:3392-3400.
17. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR: NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006, 441:595-600. (Pubitemid 43927286)
18. Yankner BA, Lu T: Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 2009, 284:4755-4759.
19. Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y: Amyloid beta protein (a beta) deposition: A beta 42(43) precedes a beta 40 in down syndrome. Ann Neurol 1995, 37:294-299.
20. Kwak YD, Brannen CL, Qu T, Kim HM, Dong X, Soba P, Majumdar A, Kaplan A, Beyreuther K, Sugaya K: Amyloid precursor protein regulates differentiation of human neural stem cells. Stem Cells Dev 2006, 15:381-389. (Pubitemid 44100015)
21. Kong J, Xu Z: Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 1998, 18:3241-3250. (Pubitemid 28186017)
22. Harris-Cerruti C, Kamsler A, Kaplan B, Lamb B, Segal M, Groner Y: Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction]. Eur J Neurosci 2004, 19:1174-1190. (Pubitemid 38387195)
23. Kurnit DM: Down syndrome: gene dosage at the transcriptional level in skin fibroblasts. Proc Natl Acad Sci USA 1979, 76:2372-2375. (Pubitemid 9184931)
24. Chung IH, Lee SH, Lee KW, Park SH, Cha KY, Kim NS, Yoo HS, Kim YS, Lee S: Gene expression analysis of cultured amniotic fluid cell with down syndrome by DNA microarray. J Korean Med Sci 2005, 20:82-87. (Pubitemid 40342212)
25. Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S: Gene expression profiling in the adult down syndrome brain. Genomics 2007, 90:647-660. (Pubitemid 350166832)
26. Olson LE, Roper RJ, Baxter LL, Carlson EJ, Epstein CJ, Reeves RH: Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev Dyn 2004, 230:581-589. (Pubitemid 38802484)
27. Yaworsky PJ, Kappen C: Heterogeneity of neural progenitor cells revealed by enhancers in the nestin gene. Dev Biol 1999, 205:309-321. (Pubitemid 29066388)
28. Drabovich AP, Diamandis EP: Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins. J Proteome Res 2010, 9:1236-1245.